Tech Company Financing Transactions
Retro Biosciences Funding Round
On 1/24/2025, Retro Biosciences raised $1 billion in Series A financing from private investors.
Transaction Overview
Company Name
Announced On
1/24/2025
Transaction Type
Venture Equity
Amount
$1,000,000,000
Round
Series A
Investors
private investors (Sam Altman)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
888 2nd Avenue
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Undisclosed
Website
Email Address
Overview
We develop therapies that meaningfully reverse age-related diseases. Retro aspires to be a generational pharma company proportional to the scale of our mission. Built as a portfolio of bets, we are driven by a culture of kindness, rigor, and versatility. We prize speed, combining an ethos of rapid iteration with investment in vertical integration to tighten feedback loops. We bet on scientists who want to maximize their impact.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joe Betts-LaCroix
Browse more venture capital transactions:
Prev: 1/24/2025: Clutch venture capital transaction
Next: 1/24/2025: Pipeshift venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs